title: Comparison of three administration schedules of cyclosporine A in humans.
authors.affiliation: Service de Néphrologie, Hôpital Notre-Dame, Université de Montréal, Québec, Canada.
authors.forename: M J
authors.initials: MJ
authors.lastname: Hébert
authors.forename: F
authors.initials: F
authors.lastname: Madore
authors.forename: J
authors.initials: J
authors.lastname: Fugère
authors.forename: F
authors.initials: F
authors.lastname: Trahan
authors.forename: S
authors.initials: S
authors.lastname: Mongrain
authors.forename: P
authors.initials: P
authors.lastname: Daloze
authors.forename: J
authors.initials: J
authors.lastname: Corman
authors.forename: C
authors.initials: C
authors.lastname: Smesters
authors.forename: M
authors.initials: M
authors.lastname: Aboujaoude
authors.forename: G
authors.initials: G
authors.lastname: St-Louis
mesh_terms: D000284:Administration, Oral; D000328:Adult; D016572:Cyclosporine / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006085:Graft Survival; D006801:Humans; D007262:Infusions, Intravenous; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D014019:Tissue Donors; D014184:Transplantation, Homologous
chemical_list: D016572:Cyclosporine; D008775:Methylprednisolone